CLINICAL GENOMICS: YOUR PARTNER IN EARLIER DETECTION.

InSure® ONE™ is a highly accurate test for detecting blood in fecal samples.

COLVERA® is a liquid biopsy test designed to detect early recurrence of colorectal cancer.

InSure ONE

InSure ONE is an easy, one-day fecal immunochemical test that uses a sample of water collected with a brush to detect lower GI bleeding.

DETECTING RESIDUAL DISEASE

COLVERA is a clinically validated circulating tumor DNA (ctDNA) blood test designed to detect residual disease after surgical resection in CRC patients.

RECURRENCE MONITORING

COLVERA is a clinically validated ctDNA blood test designed to detect recurrent disease after primary treatment in CRC patients.

TECHNOLOGY

Clinical Genomics harnesses breakthrough science to create innovative and accessible ways to detect disease and enhance lives.

COMPANY

Clinical Genomics is committed to developing and delivering solutions that provide physicians and their patients with information to help guide earlier and better treatment decisions in cancer care management.

CONTACT US

For more information about Clinical Genomics and our products.

Two new Board of Director appointments to liquid biopsy company Clinical Genomics

Two new Board of Director appointments to liquid biopsy company Clinical Genomics Bridgewater, NJ – Tuesday October 16, 2018 Clinical Genomics, a leading provider of cancer testing solutions and liquid biopsy testing, today announced two appointments to...

Clinical Genomics to Attend AAFP’s Family Medicine Experience (FMX) in New Orleans to Promote InSure® ONE for Colorectal Cancer Screening Programs

Clinical Genomics to Attend AAFP’s Family Medicine Experience (FMX) in New Orleans to Promote InSure® ONE for Colorectal Cancer Screening Programs InSure® ONE™ is an Easy, Proven, Accurate Fecal Immunochemical Test (FIT) for use in Colorectal Cancer...

Clinical Genomics is proud to support Strides for Life and Super Bowel I

Clinical Genomics is proud to support Strides for Life and Super Bowel I Overcoming the stigma associated with colorectal cancer screening; former NFL players lead the way by undertaking colonoscopy and InSure ONE FIT testing in Super Bowel I Bridgewater,...

Clinical Genomics Pathology Inc. receives licensure from State of California Department of Public Health

Clinical Genomics Pathology Inc. receives licensure from State of California Department of Public Health Bridgewater, NJ – Thursday June 14, 2018 Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that...

Social Icons

Facebook Twitter LinkedIn

Copyright © 2018 Clinical Genomics Technologies Pty Ltd. All Rights Reserved.